BACKGROUND: Sitting time is associated with adverse health outcomes including chronic disease and premature mortality. However, it is not known if the association of sitting time with cardiometabolic risk factors varies across sociodemographic or health factors. METHODS: The sample included 4560 adults (≥20 years) who participated in the cross-sectional 2007-2010 US National Health and Nutrition Examination Survey. Participants self-reported typical daily sitting time. Weight, height, blood pressure, and fasting triglycerides, high-density lipoprotein-cholesterol (HDL-C), glucose and insulin were measured. Homeostatic model assessment-insulin resistance (HOMA-IR) and β cell function (HOMA-%B) were calculated. A subsample of 3727 participants underwent an oral glucose tolerance test to obtain 2 h postload glucose levels. Population-weighted linear regression analysis was used to examine the association between sitting time and each cardiometabolic risk factor, stratified by sex, race, socioeconomic status and activity level. Analyses were controlled for demographics, socioeconomic status, survey cycle, personal and family medical history, diet and physical activity. RESULTS: Sitting time was significantly associated with adverse levels of waist circumference, body mass index, triglycerides, HDL-C, insulin, HOMA-IR, HOMA-%B and 2 h postload glucose, but not with blood pressure or glucose level. In stratified analyses, sitting time was most consistently related to cardiometabolic risk factors among low and middle socioeconomic groups and for those who reported no weekly physical activity, but there were few differences between sex or race groups. CONCLUSIONS: Self-reported sitting time was associated with adverse cardiometabolic risk factors consistently across sex and race groups in a representative US sample, independent of other risk factors. Excessive sitting warrants a public health concern.
BACKGROUND: Sitting time is associated with adverse health outcomes including chronic disease and premature mortality. However, it is not known if the association of sitting time with cardiometabolic risk factors varies across sociodemographic or health factors. METHODS: The sample included 4560 adults (≥20 years) who participated in the cross-sectional 2007-2010 US National Health and Nutrition Examination Survey. Participants self-reported typical daily sitting time. Weight, height, blood pressure, and fasting triglycerides, high-density lipoprotein-cholesterol (HDL-C), glucose and insulin were measured. Homeostatic model assessment-insulin resistance (HOMA-IR) and β cell function (HOMA-%B) were calculated. A subsample of 3727 participants underwent an oral glucose tolerance test to obtain 2 h postload glucose levels. Population-weighted linear regression analysis was used to examine the association between sitting time and each cardiometabolic risk factor, stratified by sex, race, socioeconomic status and activity level. Analyses were controlled for demographics, socioeconomic status, survey cycle, personal and family medical history, diet and physical activity. RESULTS: Sitting time was significantly associated with adverse levels of waist circumference, body mass index, triglycerides, HDL-C, insulin, HOMA-IR, HOMA-%B and 2 h postload glucose, but not with blood pressure or glucose level. In stratified analyses, sitting time was most consistently related to cardiometabolic risk factors among low and middle socioeconomic groups and for those who reported no weekly physical activity, but there were few differences between sex or race groups. CONCLUSIONS: Self-reported sitting time was associated with adverse cardiometabolic risk factors consistently across sex and race groups in a representative US sample, independent of other risk factors. Excessive sitting warrants a public health concern.
Authors: Charles E Matthews; Stephanie M George; Steven C Moore; Heather R Bowles; Aaron Blair; Yikyung Park; Richard P Troiano; Albert Hollenbeck; Arthur Schatzkin Journal: Am J Clin Nutr Date: 2012-01-04 Impact factor: 7.045
Authors: Adrian Bauman; Barbara E Ainsworth; James F Sallis; Maria Hagströmer; Cora L Craig; Fiona C Bull; Michael Pratt; Kamalesh Venugopal; Josephine Chau; Michael Sjöström Journal: Am J Prev Med Date: 2011-08 Impact factor: 5.043
Authors: K Wijndaele; N Duvigneaud; L Matton; W Duquet; C Delecluse; M Thomis; G Beunen; J Lefevre; R M Philippaerts Journal: Eur J Clin Nutr Date: 2007-10-31 Impact factor: 4.016
Authors: Carlos A Celis-Morales; Francisco Perez-Bravo; Luis Ibañez; Carlos Salas; Mark E S Bailey; Jason M R Gill Journal: PLoS One Date: 2012-05-09 Impact factor: 3.240
Authors: Alicia A Thorp; Genevieve N Healy; Neville Owen; Jo Salmon; Kylie Ball; Jonathan E Shaw; Paul Z Zimmet; David W Dunstan Journal: Diabetes Care Date: 2009-11-16 Impact factor: 19.112
Authors: Nancy López-Olmedo; Barry M Popkin; Penny Gordon-Larsen; Lindsey Smith Taillie Journal: Public Health Nutr Date: 2019-07-08 Impact factor: 4.022
Authors: Michelle N McDonnell; Susan L Hillier; Suzanne E Judd; Ya Yuan; Steven P Hooker; Virginia J Howard Journal: Prev Med Date: 2016-02-13 Impact factor: 4.018
Authors: Amanda E Staiano; Corby K Martin; Catherine M Champagne; Jennifer C Rood; Peter T Katzmarzyk Journal: Am J Clin Nutr Date: 2018-11-01 Impact factor: 7.045
Authors: Ronald C Plotnikoff; Sarah A Costigan; Camille Short; Anne Grunseit; Erica James; Natalie Johnson; Adrian Bauman; Catherine D'Este; Hidde P van der Ploeg; Ryan E Rhodes Journal: PLoS One Date: 2015-06-03 Impact factor: 3.240
Authors: John M Schuna; Catrine Tudor-Locke; Mahara Proença; Tiago V Barreira; Daniel S Hsia; Fabio Pitta; Padma Vatsavai; Richard D Guidry; Matthew R Magnusen; Amanda D Cowley; Corby K Martin Journal: BMC Res Notes Date: 2016-02-09
Authors: Michael F La Fountaine; Christopher M Cirnigliaro; Racine R Emmons; Steven C Kirshblum; Marinella Galea; Ann M Spungen; William A Bauman Journal: Lipids Health Dis Date: 2015-07-28 Impact factor: 3.876